These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 28294594

  • 1. Association of kallistatin with carotid intima-media thickness in women with polycystic ovary syndrome.
    Calan M, Guler A, Unal Kocabas G, Alarslan P, Bicer M, Imamoglu C, Yuksel A, Bozkaya G, Bilgir O.
    Minerva Endocrinol; 2018 Sep; 43(3):236-245. PubMed ID: 28294594
    [Abstract] [Full Text] [Related]

  • 2. Endocan is a predictor of increased cardiovascular risk in women with polycystic ovary syndrome.
    Bicer M, Guler A, Unal Kocabas G, Imamoglu C, Baloglu A, Bilgir O, Yuksel A, Bozkaya G, Calan M.
    Endocr Res; 2017 May; 42(2):145-153. PubMed ID: 27911121
    [Abstract] [Full Text] [Related]

  • 3. Increased adipsin is associated with carotid intima media thickness and metabolic disturbances in polycystic ovary syndrome.
    Gursoy Calan O, Calan M, Yesil Senses P, Unal Kocabas G, Ozden E, Sari KR, Kocar M, Imamoglu C, Senses YM, Bozkaya G, Bilgir O.
    Clin Endocrinol (Oxf); 2016 Dec; 85(6):910-917. PubMed ID: 27434652
    [Abstract] [Full Text] [Related]

  • 4. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
    Taskin MI, Bulbul E, Adali E, Hismiogulları AA, Inceboz U.
    Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320
    [Abstract] [Full Text] [Related]

  • 5. Clinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass index.
    Samy N, Hashim M, Sayed M, Said M.
    Dis Markers; 2009 Jun; 26(4):163-70. PubMed ID: 19729797
    [Abstract] [Full Text] [Related]

  • 6. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA, Hassan S, Nisar S, Shamas N, Rashid A, Ahmed I, Douhat S, Mudassar S, Jan VM, Rashid F.
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [Abstract] [Full Text] [Related]

  • 7. A possible connection between tumor necrosis factor alpha and adropin levels in polycystic ovary syndrome.
    Kume T, Calan M, Yilmaz O, Kocabas GU, Yesil P, Temur M, Bicer M, Calan OG.
    J Endocrinol Invest; 2016 Jul; 39(7):747-54. PubMed ID: 26969461
    [Abstract] [Full Text] [Related]

  • 8. Circulating insulin-like peptide 5 levels and its association with metabolic and hormonal parameters in women with polycystic ovary syndrome.
    Bicer M, Alan M, Alarslan P, Guler A, Kocabas GU, Imamoglu C, Aksit M, Bozkaya G, Isil AM, Baloglu A, Aslanipoiur B, Calan M.
    J Endocrinol Invest; 2019 Mar; 42(3):303-312. PubMed ID: 29956214
    [Abstract] [Full Text] [Related]

  • 9. The serum protein α2-Heremans-Schmid glycoprotein/fetuin-a concentration and carotid intima-media thickness in women with polycystic ovary syndrome.
    Abali R, Celik C, Tasdemir N, Guzel S, Alpsoy S, Yuksel A, Celik E.
    Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(1):45-9. PubMed ID: 23433744
    [Abstract] [Full Text] [Related]

  • 10. Elevated circulating levels of betatrophin are associated with polycystic ovary syndrome.
    Calan M, Yilmaz O, Kume T, Unal Kocabas G, Yesil Senses P, Senses YM, Temur M, Gursoy Calan O.
    Endocrine; 2016 Jul; 53(1):271-9. PubMed ID: 26832343
    [Abstract] [Full Text] [Related]

  • 11. The impact of body mass on inflammatory markers and insulin resistance in polycystic ovary syndrome.
    Souza Dos Santos AC, Soares NP, Costa EC, de Sá JC, Azevedo GD, Lemos TM.
    Gynecol Endocrinol; 2015 Mar; 31(3):225-8. PubMed ID: 25373529
    [Abstract] [Full Text] [Related]

  • 12. Insulin resistance and cardiovascular risk factors in women with PCOS who have normal glucose tolerance test.
    Yildir IC, Kutluturk F, Tasliyurt T, Yelken BM, Acu B, Beyhan M, Erkorkmaz U, Yilmaz A.
    Gynecol Endocrinol; 2013 Feb; 29(2):148-51. PubMed ID: 23127112
    [Abstract] [Full Text] [Related]

  • 13. Kallistatin as a marker of microvascular complications in children and adolescents with type 1 diabetes mellitus: Relation to carotid intima media thickness.
    El-Asrar MA, Andrawes NG, Ismail EA, Salem SM.
    Vasc Med; 2015 Dec; 20(6):509-17. PubMed ID: 26091968
    [Abstract] [Full Text] [Related]

  • 14. Thrombin-activatable fibrinolysis inhibitor and cardiovascular risk factors in polycystic ovary syndrome.
    Erdoğan M, Karadeniz M, Alper GE, Tamsel S, Uluer H, Cağlayan O, Saygili F, Yilmaz C.
    Exp Clin Endocrinol Diabetes; 2008 Mar; 116(3):143-7. PubMed ID: 18350479
    [Abstract] [Full Text] [Related]

  • 15. Association of serum pigment epithelium-derived factor with high-sensitivity C-reactive protein in women with polycystic ovary syndrome.
    Cheng Q, Xia W, Yang S, Ye P, Mei M, Song Y, Luo M, Li Q.
    J Endocrinol Invest; 2013 Sep; 36(8):632-5. PubMed ID: 24105071
    [Abstract] [Full Text] [Related]

  • 16. High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome.
    Verit FF.
    Arch Gynecol Obstet; 2010 Jun; 281(6):1009-14. PubMed ID: 19771438
    [Abstract] [Full Text] [Related]

  • 17. Left ventricular myocardial mass index and its correlates as an early marker of cardiovascular risk among nonobese normotensive Indian women with polycystic ovary syndrome: lessons from a cross-sectional study.
    Rashid A, Masood A, Wani IA, Hafeez I, Parvez T, Zagar MA, Ganie MA.
    Fertil Steril; 2020 Jun; 113(6):1299-1307.e2. PubMed ID: 32482259
    [Abstract] [Full Text] [Related]

  • 18. Increased serum neuregulin 4 levels in women with polycystic ovary syndrome: A case-control study.
    Temur M, Calan M, Akşit M, Yılmaz Ö, Çift T, Akselim B, Dinçgez Çakmak B, Üstünyurt E.
    Ginekol Pol; 2017 Jun; 88(10):517-522. PubMed ID: 29192411
    [Abstract] [Full Text] [Related]

  • 19. Serum resistin and adiponectin levels in young non-obese women with polycystic ovary syndrome.
    Arikan S, Bahceci M, Tuzcu A, Kale E, Gökalp D.
    Gynecol Endocrinol; 2010 Mar; 26(3):161-6. PubMed ID: 20148738
    [Abstract] [Full Text] [Related]

  • 20. Increased arterial stiffness in nonobese women with polycystic ovary syndrome (PCOS) without comorbidities: one more characteristic inherent to the syndrome?
    Soares GM, Vieira CS, Martins WP, Franceschini SA, dos Reis RM, Silva de Sá MF, Ferriani RA.
    Clin Endocrinol (Oxf); 2009 Sep; 71(3):406-11. PubMed ID: 19094071
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.